Top 5 Goals for Management of Diabetes Mellitus

Clin Brief. Nov-Dec 2021;19(8):. 38 Refs

Thomas Schermerhorn¹

¹ College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA.

Author Abstract

Diabetic patients require multiple special considerations. See how your treatment strategies compare with this expert's top 5 management goals of treatment for dogs and cats.

Article Tools:

Email to me

Archives Highlights:

Efficacy and safety of once daily oral administration of sodium-glucose cotransporter-2 inhibitor velagliflozin compared with twice daily insulin injection in diabetic cats.
On Day 45, 29/54 (54%) velagliflozin-treated cats and 26/62 (42%) Caninsulin-treated cats showed treatment success, demonstrating noninferiority. By Day 91, quality of life (QoL), polyuria, and polydipsia had improved in 81%, 54%, and 61% (velagliflozin); on blood glucose (BG) curves, mean BG was <252 mg/dL in 42/54 (78%; velagliflozin) and 37/62 (60%; Caninsulin); minimum BG was <162 mg/dL in 41/54 (76%; velagliflozin) and 41/62 (66%; Caninsulin); serum fructosamine was <450 µmol/L in 41/54 (76%; velagliflozin) and 38/62 (61%; Caninsulin).

Companion animal veterinary personnel have occupational risk for tularemia and One Health role for tularemia prevention in Kansas.
Forty-three percent (47 of 109) of veterinarians reported diagnosing tularemia in cats and 13% (14 of 109) in dogs. Seven percent (8 of 109) of veterinarians reported having had tularemia. When performing procedures with a high risk of exposure, such as lancing abscesses in tularemia suspects, glove use was 100% but additional personal protective equipment was inconsistent, including eye protection (70%) and surgical face mask (59%).

Lightning deaths in three outdoor dogs: A case study.
The three dogs were found close to each other, under a truck with a series of damages, such as burning of the tyres, the electrical control unit, and the trailer's ABS control unit.

Duration of efficacy and effect of implant location in adult queens treated with a 9.4 mg deslorelin subcutaneous implant.
The average duration of action of the 9.4 mg deslorelin implant was 790 ± 155 days (range 525-1140 days) with no significant difference in duration or efficacy depending on implantation sites. The 9.4 mg deslorelin implant causes pharmacological sterilization for about 2 years in female cats, is fully reversible, and caused no clinically relevant side effects when administered at both interscapular and periumbilical sites.

How to Address Common Misconceptions About Nutrition
Choosing the optimal food for one’s pet can evoke many emotions. Love, confusion, fear, guilt, and complacency are just some of the feelings evoked by pet food industry marketing. Navigating which concerns are valid or fabricated is challenging.